Bumper Offer - Urjas oil Just @ Rs. 1
Emigo Oral Solution is a prescription drug, available for use as Solution. It is primarily used for the treatment of Nausea and Vomiting.
The optimal dosage of Emigo Oral Solution is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Emigo Oral Solution can also lead to other problems, which have been listed below. Normally, these side effects of Emigo Oral Solution are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Emigo Oral Solution has a Safe effect for pregnant women and Mild effect on lactating mothers. In addition, Emigo Oral Solution's effects on the liver, heart and kidney are discussed below in the Emigo Oral Solution related warnings section.
Emigo Oral Solution can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Emigo Oral Solution in conditions like Heart Disease, Calcium Deficiency, Potassium Deficiency. Other contraindications of Emigo Oral Solution have been discussed in the sections ahead.
Drug reaction of Emigo Oral Solution with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Emigo Oral Solution is not safe while driving, and is is not addictive in nature.
Emigo Oral Solution is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Infant (1 month to 2 years) |
|
| 2 - 12 years (Child) |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Emigo Oral Solution is used -
Moderate
Mild
Is the use of Emigo Oral Solution safe for pregnant women?
There are no side effects of Emigo in pregnant women.
Is the use of Emigo Oral Solution safe during breastfeeding?
Emigo has been seen to have minimal side effects on breastfeeding women.
What is the effect of Emigo Oral Solution on the Kidneys?
Emigo is not harmful for kidneys.
What is the effect of Emigo Oral Solution on the Liver?
There may be an adverse effect on the liver after taking Emigo. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Emigo Oral Solution on the Heart?
Emigo can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Emigo Oral Solution should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emigo Oral Solution unless your doctor advises you to do so -
Is this Emigo Oral Solution habit forming or addictive?
Forming a habit of Emigo Oral Solution has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Emigo Oral Solution you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Emigo Oral Solution is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Emigo Oral Solution cannot treat any kind of mental disorder.
Interaction between Food and Emigo Oral Solution
Taking Emigo Oral Solution with food does not harm your health.
Interaction between Alcohol and Emigo Oral Solution
Taking alcohol with Emigo Oral Solution can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)